this company, which is principally engaged in the manufacture of skincare products, cosmetics, food supplements and medicines used to treat skin diseases. The Company paid 20 million to the seller in
addition, the Company continued to be negatively impacted by news related to manufacturers of substandard products and the closure of the biggest wholesale skincare market in the country since last April
sales structures to be more appropriate. Furthermore, the Company was negatively affected by news related to manufacturers of substandard products and the closure of the biggest wholesale skincare market
for overseas business expansion. Additionally, the Company continued to be adversely affected by news related to manufacturers of substandard products and the closure of the biggest wholesale skincare
period of the previous year as a result of negative news related to manufacturers of substandard products and the closure of the biggest wholesale skincare market in the country last April which posted a
growth was driven primarily by an increase in revenues from sales of pet skincare shampoo products, pet food products and livestock animal products, and revenues from sales of wellness & anti-ageing
for skincare, cosmetics, supplementary food and skin medicine under trademarks including trademark of “DERMALIS”, (which will be transferred on share sale and purchase date from the seller’s connected
established in 2011 and operated business Original Equipment Manufacturer or OEM for skincare, cosmetics, supplementary food and skin medicine under trademarks including trademark of “DERMALIS”, (which will be
shares Company’s name Aesthetic Zecret (At-Ze) Co., Ltd. Business type At-Ze established in 2011 and operated business Original Equipment Manufacturer or OEM for skincare, cosmetics, supplementary food and